Primary care expenditures before the onset of Alzheimer's disease

Neurology. 2002 Aug 27;59(4):573-8. doi: 10.1212/wnl.59.4.573.

Abstract

Objective: To investigate primary care expenditures in the period before diagnosis of AD.

Methods: In a population-based sample of Medicare enrollees in New York City, person-level 1996 Medicare claims, summed over primary care encounters, were examined for people who developed AD in 1997 to 1998 and those who did not.

Results: People who developed AD were more likely to use Medicare outpatient and ambulatory care 1 to 2 years before diagnosis. Compared with respondents who did not develop AD, the excess cost for men was $1,167 (85% higher) and for women $239 (26% higher). Among elderly people > or = 75 years in the United States, the prodromal period of AD was associated with an excess Medicare-based primary care cost of $128.5 to $194.7 million.

Conclusion: In addition to huge costs associated with AD after diagnosis, prediagnosis costs are an unrecognized source of expenditures related to the disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / economics*
  • Alzheimer Disease / ethnology
  • Ambulatory Care / economics
  • Ambulatory Care / statistics & numerical data
  • Black or African American / statistics & numerical data
  • Cognition Disorders / economics*
  • Cognition Disorders / ethnology
  • Cohort Studies
  • Comorbidity
  • Disease Progression
  • Female
  • Health Expenditures / statistics & numerical data*
  • Hispanic or Latino / statistics & numerical data
  • Humans
  • Longitudinal Studies
  • Male
  • Medicare / economics*
  • Medicare / statistics & numerical data*
  • New York City / epidemiology
  • Primary Health Care / economics*
  • Primary Health Care / statistics & numerical data
  • Sex Distribution
  • United States
  • White People / statistics & numerical data